All Stories

  1. Clinical Outcomes of Ceftazidime–Avibactam versus Ceftolozane–Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy

    Article • Antibiotics, July 2024, MDPI AG

    Diaa Alrahmany

  2. Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies

    Article • Journal of Clinical Medicine, April 2024, MDPI AG

    Diaa Alrahmany

  3. Infections in Glucose-6-Phosphate Dehydrogenase G6PD-Deficient Patients; Predictors for Infection-Related Mortalities and Treatment Outcomes

    Article • Antibiotics, March 2023, MDPI AG

    Diaa Alrahmany

  4. Immune Response to Bacterial Infections in Hospitalized Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients; Diagnostic Value of Complete Blood Count

    Article • January 2023, Elsevier

    Diaa Alrahmany

  5. Immune Response to Bacterial Infections in Hospitalized Glucose-6-Phosphate Dehydrogenase (G6pd)-Deficient Patients; Diagnostic Value of Complete Blood Count

    Article • January 2023, Elsevier

    Diaa Alrahmany

  6. Acinetobacter baumannii Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions

    Article • Antibiotics, August 2022, MDPI AG

    Diaa Alrahmany

  7. Infections in G6PD-Deficient Hospitalized Patients—Prevalence, Risk Factors, and Related Mortality

    Article • Antibiotics, July 2022, MDPI AG

    Diaa Alrahmany

  8. Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients

    Article • Journal of Infection and Public Health, November 2021, Elsevier

    Diaa Alrahmany

  9. Acinetobacter baumannii Infections in Hospitalized Patients, Treatment Outcomes

    Article • Antibiotics, May 2021, MDPI AG

    Diaa Alrahmany

  10. Multi-drug resistant Acinetobacter baumannii infection, risk factors for mortality

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Diaa Alrahmany

  11. Clostridium difficile infection risk of recurrence and candidates for preventive therapy, a stewardship approach

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Diaa Alrahmany

  12. Evolving Rapid Diagnostics Tools

    Article • November 2020, Bentham Science Publishers

    Islam Ghazi, Diaa Alrahmany

  13. Molecular Basis of Resistance II

    Article • November 2020, Bentham Science Publishers

    Islam Ghazi, Diaa Alrahmany

  14. Molecular Basis of Resistance III

    Article • November 2020, Bentham Science Publishers

    Islam Ghazi, Diaa Alrahmany

  15. 21st Century Challenges in Antimicrobial Therapy and Stewardship

    Article • November 2020, Bentham Science Publishers

    Islam Ghazi, Diaa Alrahmany

  16. Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options

    Article • Reviews in Medical Microbiology, August 2020, Wolters Kluwer Health

    Diaa Alrahmany

  17. Optimal vancomycin dose in the treatment of Clostridium difficile infection, antimicrobial stewardship initiative

    Article • Journal of Chemotherapy, July 2020, Taylor & Francis

    Diaa Alrahmany

  18. Risk factors associated with the mortality of Acinetobacter baumannii

    Article • Access Microbiology, July 2020, Society for General Microbiology

    Diaa Alrahmany

  19. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program

    Article • International Journal of Infectious Diseases, June 2019, Elsevier

    Diaa Alrahmany

  20. Bacterial resistance Oman

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Diaa Alrahmany